The Endothelial Cell in Lung Inflammation

Dear Colleagues,

The current COVID-19 pandemic has placed unprecedented emphasis on better understanding the molecular mechanisms driving lung injury, a major determinant of COVID-19-related morbidity and mortality. Increased lung capillary endothelial permeability along with reduced alveolar liquid clearance capacity are major pathologic mechanisms of pulmonary edema and its life-threatening complication, the acute respiratory distress syndrome (ARDS). In addition to its well-documented role in COVID-19, ARDS is also common in other life-threatening conditions such as bacterial pneumonia, ventilator-induced lung injury, sepsis, polytrauma, chemical lung injury, etc. Thus, proper control of lung barrier function and innate immunity aided by better understanding of underlying genetic variances, ARDS-associated epigenetic alterations and interactions between endothelial, lung epithelial, and immune cells is key to developing new therapeutic approaches promoting recovery of endothelial barrier, normal lung function, and improvement of patient survival.

This Topical Collection on “The Endothelial Cell in Lung Inflammation” will showcase latest developments by leading research and clinical groups across the nation that shed the light on the complex roles of lung vascular endothelium in pathophysiology of ARDS and lung recovery. I invite topic reviews as well as full size research papers to compile this timely and important journal issue. 

I look forward to your prominent contributions.

Prof. Dr. Konstantin G Birukov
Collection Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.